Evidence map›Paper›PMID 35616780›Full record

Trial reportActa neurologica Belgica2022

Comparison of telerehabilitation versus home-based video exercise in patients with Duchenne muscular dystrophy: a single-blind randomized study.

Ozge Kenis-Coskun, Sena Imamoglu, Berna Karamancioglu, Kubra Kurt, Gulten Ozturk, Evrim Karadag-Saygi

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Acta neurologica Belgica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Fully personalized modelling of Duchenne Muscular Dystrophy ambulation.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Impact of the COVID-19 pandemic on neuromuscular rehabilitation setting. Part 2: patients and families' views on the received health care during the pandemic.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2022
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ozge Kenis-CoskunPhysical Medicine and Rehabilitation Department, Marmara University Medical Faculty, Marmara University Pendik Research and Training Hospital Istanbul, Istanbul, Turkey. ozgekenis@gmail.com.ORCID http://orcid.org/0000-0002-3004-1992
Sena ImamogluPhysical Medicine and Rehabilitation Department, Marmara University Medical Faculty, Marmara University Pendik Research and Training Hospital Istanbul, Istanbul, Turkey.
Berna KaramanciogluPhysical Medicine and Rehabilitation Department, Marmara University Medical Faculty, Marmara University Pendik Research and Training Hospital Istanbul, Istanbul, Turkey.
Kubra KurtPhysical Medicine and Rehabilitation Department, Marmara University Medical Faculty, Marmara University Pendik Research and Training Hospital Istanbul, Istanbul, Turkey.
Gulten OzturkPediatric Neurology Department, Marmara University Medical Faculty, Istanbul, Turkey.
Evrim Karadag-SaygiPhysical Medicine and Rehabilitation Department, Marmara University Medical Faculty, Marmara University Pendik Research and Training Hospital Istanbul, Istanbul, Turkey.
Marmara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPatients with Duchenne muscular dystrophy (DMD) have lost their access to on-site rehabilitation due to the COVID-19 pandemic. Telerehabilitation can be a viable approach for these patients to protect their muscle strength and functional status. The aim of this study is to compare telerehabilitation with home-based video exercises. PATIENTS AND

methodsMale, ambulatory DMD patients were randomized into telerehabilitation and video-exercise groups. Nineteen patients were included in the final analyses. Telerehabilitation consisted of live online exercises, while video exercise implemented a pre-recorded video as a home-based program. Both programs spanned 8 weeks, three times a week. Patients' muscle strength with a hand-held dynamometer, Quick Motor Function Test, North-Star Ambulatory Assessment (NSAA), 6-Minute Walk Test (6MWT) and Caregiver Burden were recorded before and after treatment.

resultsThe 6MWT of the telerehabilitation group was391.26 ± 95.08 m before and387.75 ± 210.93 after treatment (p = 0.94) and 327.46 ± 103.88 m before treatment and313.77 ± 114.55 after treatment in video group (p = 0.63). The mean NSAA score of the telerehabilitation group were26.70 ± 8.04 before treatment and 25.20 ± 11.33 after treatment (p = 0.24). In the video group scores were 21.66 ± 6.65 before to 22.00 ± 8.61 after treatment (p = 0.87). There were no significant changes between groups at the end of the treatments. The telerehabilitation group's neck extension, bilateral shoulder abduction, and left shoulder flexion, bilateral knee flexion and extension, bilateral ankle dorsiflexion, and left ankle plantar flexion strength improved significantly and were better than the video group (p < 0.05 for all measurements).

conclusionA telerehabilitation approach is superior in improving muscle strength than a video-based home exercise, but none of the programs improved functional outcomes in ambulatory patients with DMD.

Indexed as

COVID-19Muscular Dystrophy, DuchenneTelerehabilitationExercise TherapyHumansMalePandemicsSingle-Blind Method

Identifiers

PMID35616780
PMCPMC9133319
OpenAlexW4281571162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.